Display options
Cite
Ghys PD, Williams BG, Over M, et al. Epidemiological metrics and benchmarks for a transition in the HIV epidemic. PLoS Med. 2018;15(10):e1002678doi: 10.1371/journal.pmed.1002678.
Ghys, P. D., Williams, B. G., Over, M., Hallett, T. B., & Godfrey-Faussett, P. (2018). Epidemiological metrics and benchmarks for a transition in the HIV epidemic. PLoS medicine, 15(10), e1002678. https://doi.org/10.1371/journal.pmed.1002678
Ghys, Peter D, et al. "Epidemiological metrics and benchmarks for a transition in the HIV epidemic." PLoS medicine vol. 15,10 (2018): e1002678. doi: https://doi.org/10.1371/journal.pmed.1002678
Ghys PD, Williams BG, Over M, Hallett TB, Godfrey-Faussett P. Epidemiological metrics and benchmarks for a transition in the HIV epidemic. PLoS Med. 2018 Oct 25;15(10):e1002678. doi: 10.1371/journal.pmed.1002678. eCollection 2018 Oct. PMID: 30359372; PMCID: PMC6201869.
Copy Download .nbib Format: NLM
Share it on

PLoS Med. 2018 Oct 25;15(10):e1002678. doi: 10.1371/journal.pmed.1002678. eCollection 2018 Oct.

Epidemiological metrics and benchmarks for a transition in the HIV epidemic.

PLoS medicine

Peter D Ghys, Brian G Williams, Mead Over, Timothy B Hallett, Peter Godfrey-Faussett

Affiliations

  1. Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland.
  2. South Africa Centre for Epidemiological Modelling and Analysis, Stellenbosch, South Africa.
  3. Center for Global Development, Washington, DC, United States of America.
  4. Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.

PMID: 30359372 PMCID: PMC6201869 DOI: 10.1371/journal.pmed.1002678

Abstract

Peter Godfrey-Faussett and colleagues present six epidemiological metrics for tracking progress in reducing the public health threat of HIV.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. AIDS. 2005 Jan 28;19(2):193-201 - PubMed
  2. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):3-9 - PubMed
  3. Int J Epidemiol. 2016 Feb;45(1):83-93 - PubMed
  4. Lancet HIV. 2017 Oct;4(10):e457-e464 - PubMed
  5. PLoS Med. 2017 Dec 12;14(12):e1002468 - PubMed
  6. Indian J Med Res. 2017 Jul;146(1):83-96 - PubMed
  7. AIDS. 2017 Apr;31 Suppl 1:S5-S11 - PubMed
  8. AIDS. 2006 Sep 11;20(14):1898-901 - PubMed
  9. J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):236-8 - PubMed
  10. Int J STD AIDS. 2009 Dec;20(12):876-8 - PubMed
  11. Lancet HIV. 2015 Feb;2(2):e64-70 - PubMed
  12. AIDS. 2017 Apr;31 Suppl 1:S77-S85 - PubMed
  13. Int J STD AIDS. 2004 Dec;15(12):789-92 - PubMed
  14. Epidemiol Infect. 2004 Dec;132(6):1139-49 - PubMed
  15. AIDS. 2011 Sep 24;25(15):1905-13 - PubMed
  16. Lancet. 2017 Jul 22;390(10092):341-343 - PubMed
  17. AIDS. 2016 Mar 13;30(5):771-8 - PubMed
  18. Bull World Health Organ. 2011 Apr 1;89(4):278-85 - PubMed
  19. PLoS One. 2016 May 09;11(5):e0154893 - PubMed
  20. Lancet. 2017 Jul 22;390(10092):357 - PubMed
  21. Lancet HIV. 2016 Aug;3(8):e361-e387 - PubMed
  22. Lancet. 2009 Jan 3;373(9657):48-57 - PubMed
  23. Epidemiology. 2015 Sep;26(5):653-60 - PubMed
  24. Lancet HIV. 2017 Feb;4(2):e83-e92 - PubMed
  25. AIDS. 2017 Apr;31 Suppl 1:S1-S4 - PubMed
  26. Sex Transm Infect. 2012 Dec;88 Suppl 2:i86-94 - PubMed

MeSH terms

Publication Types

Grant support